Head-to-head · Cost-Efficiency Index
REMEVi vs Trava Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Visit REMEViTrava Health
Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner.
Visit Trava HealthThe verdict
REMEVi takes it, leading the Cost-Efficiency Index 80 to 78. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. Trava Health still earns a C — Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | Trava Health |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 78/100 |
| Semaglutide / mo | $219/mo | $88/mo (starting dose, compounded) |
| Tirzepatide / mo | $319/mo | $178/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,628 | $1,056 |
| Tirzepatide / yr (modeled) | $3,828 | $2,136 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #33 | #39 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Trava Health
78/100Where the value is
- Transparent quarterly-package discount is disclosed in dollar terms, not just a vague percentage
- HSA/FSA eligible
- Named legal entity and Houston, TX address disclosed in the Terms of Service
The tradeoffs
- Homepage 'As low as' price for semaglutide was NOT stable across repeated reads today ($88.65 vs $117.96) — this is a live, in-session finding, not a hypothetical risk
- Trava's own Terms of Service states the service is 'currently only available to individuals who are located in Texas,' contradicting nationwide/50-state marketing claims elsewhere on the site — unresolved contradiction
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.